BioSpace News Archive

ChromaCode, a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation.

Bolden Therapeutics, Inc. today announced their upcoming presentation at the BIO International Convention during Jun 5th -8th in Boston, MA.

Baudax Bio, Inc. today announced additional results from its Phase 2 clinical trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery.

Novir has announced the launch of their refreshed brand, dedicated to showcasing the evolution Novir has taken from a COVID-19 testing and vaccination provider to a more comprehensive healthcare solution committed to advancing healthcare from sick-care to pre-care by offering affordable, accessible, and reliable screening solutions to anyone, anywhere, anytime.

Lunaphore and Cell Signaling Technology announced a partnership to enable the use of CST® antibodies on the Lunaphore COMET™ platform, a scalable hyperplex imaging solution for fully automated spatial biology.

Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the “Company”), a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines,

hC Bioscience announced its tRNA-based therapy demonstrated proof-of-concept in an in vivo model of metastatic colorectal cancer with 75% tumor growth inhibition.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces it will host a Key Opinion Leader webinar on Proof-of-Concept Phase 2a study preliminary results of SENS-401 for residual hearing preservation following cochlear implantation.

IRay Technology Co., Ltd., a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.

CymaBay Therapeutics, Inc. announced it will make three presentations at the European Association for the Study of the Liver ‘s The International Liver Congress™ 2023.